Indiana Ophthalmics faces CDSCO probe; Pharmexcil may suspend membership

CDSCO starts probe based in complaint by Sri Lanka that eyedrops made by the firm are linked to eye infections in more than 30 people

Trouble for Indian drug exporters continues with the Central Drugs Standard Control Organisation (CDSCO) investigating a complaint raised by Sri Lanka that eye drops made by a Gujarat-based firm are linked to eye infections in more than 30 people in the neighbouring country. Moreover, Indiana Ophthalmics, the Gujarat-based manufacturer, has now received a show-cause notice from the Pharmaceutical Exports Promotion Council (Pharmexcil). Its membership may be cancelled if it fails to respond by Saturday.

Indiana Ophthalmics is registered with the National Medicines Regulatory Authority of Sri Lanka and has been supplying prednisolone eye drops that are used to treat inflammation